Metabolism of bis(2-chloroethyl)ether and bis(2-chloroisopropyl)ether in the rat.
R D Lingg, W H Kaylor, S M Pyle, M M Domino, C C Smith, G F Wolfe
Index: Arch. Environ. Contam. Toxicol. 11(2) , 173-83, (1982)
Full Text: HTML
Abstract
Male rats were given single peroral doses of bis(1-14C-2-chloroethyl)ether ([1-14C]BCEE) (40 mg/kg) and of bis(1-14C-2-chloroisopropyl)ether ([1-14C]BCIE) (90 mg/kg). Excretion of 14CO2 and urinary 14C was followed for 48 hr. The time required to eliminate one half of the dose was 12 hr for [1-14C]BCEE and 19 hr for [1-14C]BCIE. In the case of [1-14C]BCEE, expired 14CO2 accounted for 11.5 +/- 5.6(SD)% of the dose, urinary 14C accounted for 64.7 +/- 14.8%, and 2.4 +/- 1.3% was found in the feces. The figures for [1-14C]BCIE were 20.3 +/- 9.4% expired as 14CO2, 47.5 +/- 8.1% as urinary 14C, and 3.8 +/- 0.3% as fecal 14C. Thiodiglycolic acid (TDGA) accounted for roughly 75% of the total urinary 14C collected after the [1-14C]BCEE dose. Lesser metabolites of BCEE were 2-chloroethoxyacetic acid (CEAA) (5%), and N-acetyl-S-[2-(2-chloroethoxy)ethyl]-L-cysteine (ACEEC) (7%). Metabolites of [1-14C]BCIE identified in rat urine were 2-(2-chloro-1-methylethoxy)propanoic acid (CMEPA), roughly 36% of the total urinary 14C, and N-acetyl-S-(2-hydroxypropyl)-L-cysteine (AHPC) at 19%.
Related Compounds
Related Articles:
Carcinogenicity tests of certain environmental and industrial chemicals.
1981-07-01
[J. Natl. Cancer Inst. 67(1) , 75-88, (1981)]
Thiodiglycolic acid: a major metabolite of bis(2-chloroethyl)ether.
1979-01-01
[Toxicol. Appl. Pharmacol. 47(1) , 23-34, (1979)]
1999-01-01
[IARC Monogr. Eval. Carcinog. Risks Hum. 71 Pt 3 , 1265-9, (1999)]
[Medical topics: bischloromethyl ether and lung cancer].
1985-12-01
[Kango. 37(14) , 82, (1985)]
2009-01-01
[Water Res. 43(16) , 3910-21, (2009)]